Get the Stockscreener App
28.36
0.07%
0.02
After Hours:
28.36
Elevance Health Inc stock is traded at $28.36, with a volume of 53,452.
It is up +0.07% in the last 24 hours and down -1.25% over the past month.
See More
Previous Close:
$28.34
Open:
$28.35
24h Volume:
53,452
Relative Volume:
1.17
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.64%
1M Performance:
-1.25%
6M Performance:
-0.18%
1Y Performance:
+9.03%
1-Day Range:
$28.29
$28.40
1-Week Range:
$28.09
$28.50
52-Week Range:
$25.64
$29.97
Elevance Health Inc Stock (EELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
404-892-0896
Address
1331 SPRING STREET NW, ATLANTA
Compare EELV vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EELV
Elevance Health Inc
|
28.36 | 0 | 0 | 0 | 0 | 0.00 |
UNH
Unitedhealth Group Inc
|
436.35 | 382.83B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
110.60 | 137.30B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
393.44 | 82.89B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
290.49 | 75.11B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
404.34 | 47.81B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (EELV) Latest News
Elevance Health stock trades steadily as earnings and Medicare growth shape investor focus - Ad-hoc-news.de
The Hidden Engine Behind Elevance Health Stock's Next Climb - Trefis
Elevance Health stock trades steadily as earnings and Medicaid growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health Inc Stock Price Live, Charts & News - The Economic Times
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now? - The Motley Fool
AE1D Bond Profile — Key Metrics - TradingView
AE1J Bond Profile — Key Metrics - TradingView
Elevance Health President Acquires 1.9% More Stock - Moomoo
Elevance Health, Inc. (ELV) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health stock trades steadily as revenue and earnings grow - ad-hoc-news.de
Elevance Health director Peru buys $366,050 in company stock - Investing.com UK
Elevance Preparing to Exit Several Medicaid States - RamaOnHealthcare
Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 - Bitget
Elevance Health Price Target Raised to $395.00/Share From $364.00 by Leerink Partners - Moomoo
Insider Buying: Ramiro Peru Acquires Shares of Elevance Health I - GuruFocus
Elevance Health CEO Snaps Up Stock After Post-Earnings Slide - Barron's
What’s A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets? - Trefis
Elevance Health director Peru buys $366,050 in company stock By Investing.com - Investing.com South Africa
Elevance Health, Inc. (ELV) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. $ELV Shares Acquired by Bank of New York Mellon Corp - InsuranceNewsNet
What's a Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets? - Trefis
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook? - The Motley Fool
Elevance Health (NYSE: ELV) director purchases 1,000 shares at $366 - Stock Titan
Form 4 Elevance Health Inc For: 17 July By Investing.com - Investing.com South Africa
Elevance Health (NYSE: ELV) CEO Gail Boudreaux purchases 2,725 shares - Stock Titan
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock By Investing.com - Investing.com South Africa
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock - Investing.com India
Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform Rating - Moomoo
Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform Rating - Moomoo
Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says - Moomoo
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE) - The Globe and Mail
Elevance Health 2Q Medical Enrollment Members 44.9M >ELV - Moomoo
Lobbying Update: $60,000 of ELEVANCE HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Elevance Health earnings call: growth levers amid strain - The Globe and Mail
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
AE1N Bond Profile — Key Metrics - TradingView
RBC Lowers Price Target on Elevance Health to $424 From $439, Keeps Sector Perform Rating - Moomoo
Goldman Sachs Adjusts Price Target on Elevance Health to $395 From $370, Maintains Neutral Rating - Moomoo
Guggenheim Adjusts Price Target on Elevance Health to $455 From $399, Maintains Buy Rating - Moomoo
Wells Fargo Adjusts Price Target on Elevance Health to $473 From $492, Maintains Overweight Rating - Moomoo
ETFs Investing in Mesaieed Petrochemical Holding Company Q.S.C. Stocks - TradingView
Elevance Health Stock Weakness Despite Q2 Beat Reflects Medicaid Utilization Pressure, RBC Capital Markets Says - marketscreener.com
Elevance Health Stock Tumbles Despite Revenue Beat and Raised Full-Year Guidance - TIKR.com
Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF - The Motley Fool
Elevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructive - Yahoo Finance
The Medicaid Problem Weighing On Elevance Health Stock - Yahoo Finance
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings - Benzinga
Baird Adjusts Price Target on Elevance Health to $393 From $331, Maintains Neutral Rating - marketscreener.com
Jefferies Adjusts Price Target on Elevance Health to $450 From $393, Maintains Buy Rating - marketscreener.com
Elevance Health Inc Stock (EELV) Financials Data
There is no financial data for Elevance Health Inc (EELV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.90%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):